Heparin Resistance: Predictors and Outcomes

NACompletedINTERVENTIONAL
Enrollment

199

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

September 30, 2008

Conditions
Off Pump Coronary Artery Bypass Surgery
Interventions
DRUG

Heparin

150 U/kg heparin was administered intravenously at the beginning of graft anastomosis and accepted a perioperative ACT value of around 300 s. Ten minutes after the loading dose, the ACT was measured. An ACT of 300 s or greater was considered as adequate. Then follow up ACT measurement was determined after 30 min from the previous ACT measurement. If ACT fell below the target value of 300 s, an additional dose of heparin was administered. If ACT was between 250 and 299 s, additional 2000 U of heparin was administered and if ACT was between 200 and 249 s then additional 3000 U of heparin was injected. Ten minutes after additional heparin injection, ACT was remeasured.

Trial Locations (1)

Unknown

Yonsei University Severance hospital, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT01044888 - Heparin Resistance: Predictors and Outcomes | Biotech Hunter | Biotech Hunter